Related Experiment Video
Updated: May 3, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Treatment of mechanical aortic valve thrombosis with heparin and eptifibatide
Amit N Vora1, Thomas Gehrig, Thomas M Bashore
1Duke University Medical Center, 2301 Erwin Road Room 7411A, Durham, NC, 27710, USA, a.vora@duke.edu.
Insights
This study reports the successful use of eptifibatide and heparin to treat subacute mechanical aortic valve thrombosis. This approach offers a viable alternative for high-risk patients ineligible for surgery or fibrinolysis.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Pharmacology
Background:
- Mechanical aortic valve thrombosis presents a significant clinical challenge, particularly in patients with high surgical risks.
- Optimal management strategies for subacute valve thrombosis remain debated, especially when standard treatments are contraindicated.
Observation:
- A 75-year-old female with a history of coronary artery bypass grafting and aortic valve replacement developed progressive dyspnea and chest discomfort.
- Echocardiography showed a significant increase in aortic valve gradient, and fluoroscopy revealed mechanical valve thrombosis.
- The patient had contraindications for both repeat surgery and fibrinolysis due to comorbidities and a recent subdural hematoma.
Findings:
- Treatment with unfractionated heparin and eptifibatide resulted in the resolution of subacute mechanical aortic valve thrombosis.
- This marks the first reported successful use of eptifibatide in conjunction with heparin for this specific clinical scenario.
Implications:
- Eptifibatide combined with heparin may represent a safe and effective therapeutic option for selected patients with subacute mechanical aortic valve thrombosis.
- This finding could expand treatment possibilities for patients deemed high-risk for conventional interventions.
Abstract:
A 75-year old woman with a history of coronary disease status post 3-vessel coronary artery bypass grafting (CABG) 8 years ago and a repeat one-vessel CABG 2 years ago in the setting of aortic valve replacement with a #19 mm St. Jude bileaflet mechanical valve for severe aortic stenosis presented with two to three weeks of progressive dyspnea and increasing substernal chest discomfort. Echocardiography revealed a gradient to 31 mmHg across her aortic valve, increased from a baseline of 13 mmHg five months previously. Fluoroscopy revealed thrombosis of her mechanical aortic valve. She was not a candidate for surgery given her multiple comorbidities, and fibrinolysis was contraindicated given a recent subdural hematoma 1 year prior to presentation. She was treated with heparin and eptifibatide and subsequently demonstrated resolution of her aortic valve thrombosis. We report the first described successful use of eptifibatide in addition to unfractionated heparin for the management of subacute valve thrombosis in a patient at high risk for repeat surgery or fibrinolysis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aortic Regurgitation III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Mitral Stenosis III: Medical Management

